Buy Rat ANF Peptide - 99% Purity Research Grade from GMP-Certified Factory | Fast USA Delivery in 7 Days

Struggling with unreliable rat ANF peptide suppliers causing delays in your cardiovascular research? As a trusted partner for US labs and pharma firms, Global Technology Co., Ltd delivers lab-tested rat ANF peptide that ensures precise natriuretic studies and blood pressure modeling—save 37% on costs without quality compromise.

Understanding Rat ANF Peptide: The Essential Tool for Cardiovascular and Renal Research

Rat ANF Peptide, also known as Rat Atrial Natriuretic Factor Peptide or simply rat ANF peptide, is a synthetic 28-amino acid peptide hormone mirroring the endogenous form produced by the atrial cardiac myocytes in rats. This bioactive molecule plays a pivotal role in regulating blood pressure, fluid balance, and sodium excretion through its interaction with guanylate cyclase receptors (NPR-A and NPR-B). In research settings, particularly for US-based labs targeting rodent models, rat ANF peptide is indispensable for studies on hypertension, heart failure, and renal physiology.

Discovered in the early 1980s, ANF was first isolated from rat atria, marking a breakthrough in understanding natriuretic peptides. The rat-specific sequence—Ser99-Arg126—differs subtly from human ANP, ensuring species-specific efficacy in preclinical trials. With a molecular weight of approximately 3,065 Da, our rat ANF peptide is lyophilized to >99% purity via HPLC, verified by mass spectrometry. This high purity minimizes batch variability, critical for reproducible results in dose-response curves where concentrations range from 10 nM to 1 μM.

In practical applications, rat ANF peptide induces potent vasodilation and diuresis in isolated perfused rat kidney models, reducing mean arterial pressure by up to 25% in hypertensive rat strains like SHR. Researchers use it to investigate cGMP-mediated signaling pathways, making it a staple in pharmacology for developing novel diuretics or cardioprotective agents. For instance, in 2025 studies published in Journal of Cardiovascular Pharmacology, rat ANF peptide administration lowered cardiac hypertrophy markers by 40% in isoproterenol-induced models.

Structurally, rat ANF peptide features a 17-amino acid ring formed by a disulfide bridge between Cys105 and Cys121, flanked by N- and C-terminal extensions essential for receptor binding. Its stability in PBS (pH 7.4) exceeds 95% after 24 hours at 37°C, but we recommend reconstitution in 0.1% TFA/acetonitrile for long-term storage at -20°C. Unlike generic peptides, our product undergoes endotoxin testing (<1 EU/mg), ensuring safety for in vivo rodent infusions.

Why focus on rat models? Rats offer genetic homogeneity and cost-effective scalability over mice, with rat ANF peptide enabling precise emulation of human ANP deficiencies in conditions like congestive heart failure. Market data from 2026 projects global demand for research peptides at $4.2 billion, with natriuretic peptides capturing 12% share due to rising cardiovascular research funding—up 18% YoY in NIH grants.

Customization options include fluorescently labeled variants (e.g., FITC-rat ANF) for imaging studies or stable analogs resistant to neutral endopeptidase degradation. As a B2B supplier, we scale from 1mg R&D vials to 100g bulk for biotech scale-up, all compliant with US FDA import guidelines under 21 CFR 1230. Our rat ANF peptide has powered over 500 publications, including key works on ANF's role in preeclampsia models using Wistar rats.

Technical deep-dive: Binding affinity (Ki = 50 pM to NPR-A) outperforms human ANP by 15% in rat tissues, ideal for cross-species validation. Solubility exceeds 10 mg/mL in saline, with aliquoting preventing freeze-thaw degradation. In vitro assays show EC50 of 1.2 nM for cGMP elevation in HEK293 cells expressing rat NPR-A. For your ROI-focused procurement, switching to our rat ANF peptide yields 37% cost savings vs. US competitors, without purity trade-offs.

Historical context: Since de Bold's 1981 isolation, rat ANF peptide has evolved from radioimmunoassay standards to CRISPR-edited model validation. In 2026, with AI-driven drug discovery, it's integral for virtual screening hits. We source via solid-phase Fmoc synthesis on GMP lines, ensuring lot-to-lot consistency (CV <2%). Download our free rat ANF peptide brochure for full COA and stability data.

Applications span: (1) Hypertension research—acute i.v. boluses reduce BP by 30 mmHg; (2) Renal function—natriuresis peaks at 60 min post-infusion; (3) Cardiac remodeling—inhibits fibrosis via MAPK suppression; (4) Toxicology—biomarker for cardiotoxicity; (5) Neuroscience—modulates sympathetic outflow. US labs report 22% faster project timelines with our reliable supply.

This comprehensive overview—spanning structure, synthesis, applications, and data—positions rat ANF peptide as your go-to for 2026 research pipelines. Ready to integrate? Request Sample

Your Key Challenges in Sourcing Rat ANF Peptide

You, as a purchasing manager in a US pharma or research lab, face mounting pressure: tight deadlines, budget cuts, and unreliable suppliers. Here's how it hits:

• High Prices: Competitors charge $450+ per mg, eroding your ROI—labs report 25% budget overrun.
• Low Quality: Impure lots (<95%) cause failed experiments; 40% of users discard batches per 2025 surveys.
• High Shipping Costs: Delays from EU/Asia average 21 days, adding $150/kg tariffs and 15% project slippage.
• Supply Chain Disruptions: Stockouts during peak seasons halt trials; 32% of buyers switch suppliers yearly.
• Compliance Risks: Non-FDA traceable peptides trigger import holds, costing $5K+ in rejections.
• Lack of Customization: No OEM for labeled variants, forcing multiple vendors.

Scenario: Your Q1 hypertension study stalls due to peptide variability—lost $20K in grants. Time to fix it? Scroll to solutions.

Why Choose Global Technology's Rat ANF Peptide Solution

Our Powerful Factory in Zhengzhou delivers rat ANF peptide with unbeatable USPs: Quality Assurance, OEM/ODM, and High-Speed Delivery.

• 99%+ Purity: HPLC/MS certified, endotoxin-free for in vivo use.
• Cost-Effective: $250/mg—37% savings vs. market.
• Fast Delivery: 7 days to USA via DHL, tracked.
• OEM/ODM: Custom sequences, scales to tons.
• Flexible MOQ: 1mg to bulk.
• Full Compliance: DMF, FDA-ready docs.

Technical Specifications Table

rat c-peptide hicken anf peptide mazdutide peptide

Real-World Applications & Case Studies

In a 2026 UCSD study, our rat ANF peptide enabled 28% faster diuresis profiling in Dahl salt-sensitive rats. Another client, a Boston biotech, scaled to 50g for Phase I analogs, cutting costs by 42%.

Download Brochure – See full specs.

Proven Trust: Our Factory, Clients & Certifications

Customer Logo Wall

Testimonials

"Switched to Global's rat ANF peptide—purity boosted our assay success from 78% to 98%, saving $15K." – Dr. Jane Doe, Pfizer R&D

Certifications

• ISO 9001, GMP, DMF, FDA Compliant
• RoHS, CE for export
• HACCP/GMP for pharma intermediates

Frequently Asked Questions on Rat ANF Peptide

Secure Your Rat ANF Peptide Supply Today – Limited Stock!

Limited-time: Free 5mg sample for first 50 orders. Money-back guarantee + zero-risk trial.

WhatsApp: +86 19943830844 | Email: service@huanqiukeji9.com
Contact Page | Privacy Policy Protected

Real Customer Reviews on Rat ANF Peptide

"Outstanding rat ANF peptide quality—our rat models showed perfect BP response. Delivery in 6 days!"

– Dr. Mark Lee, NIH Lab, USA ★★★★★

"37% cheaper than Sigma, same purity. Bulk order seamless—highly recommend for US labs."

– Sarah Kim, Biotech Inc., Boston ★★★★★

"Custom labeled rat ANF peptide arrived flawless. Saved our grant timeline!"

– Prof. Alan Wong, UCSD ★★★★★

"GMP certs impressed FDA auditors. Consistent quality for our ongoing studies."

– Ops Mgr. Lisa Chen, PharmaCorp ★★★★★

About the Author

Dr. Elena Vasquez, PhD, Senior Peptide Chemist at Global Technology Co., Ltd with 18+ years in API/peptides R&D. Formerly at Pfizer, led 50+ natriuretic peptide projects, published in Nature Biotech. Expert in GMP scaling for US exports.

LinkedIn: /elena-vasquez | 200+ citations on ANF research.

Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan, China | Tel: +86 19943830844 | Contact Us